Contextually, compared with the G/G genotype, C/C or G/C genotypes are associated with higher severity of RA, due to increased IL-6 production which in turn reduces responsiveness to biological agent therapy [16,17]. The gene discussed is IL6; the disease is rheumatoid arthritis.